Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Pills leaning against coinsThe U.S. government should set prices for coronavirus vaccines and therapies to prevent price gouging, a coalition of companies and other employers said.

Medicare, the health program serving older Americans, should determine fair prices for Covid-19 drugs and inoculations that would also be paid by organizations and individuals, Employers’ Prescription for Affordable Drugs said in a statement. The group cited Gilead Sciences Inc.’s remdesivir antiviral as an example of an overpriced therapy.

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.